Todd Hyatt
Analyst · RBC. You may begin
Thank you, Lance. Before we get started with the results, I want to remind you that while Q1 results include IHS and Markit, prior year Q1 results only include legacy IHS. We've included Markit's year-over-year organic revenue growth and FX revenue impact in our revenue growth rates, and have included the remainder of Markit revenue as acquisitive revenue growth. Our Q1 absolute and organic revenue growth rates have also been normalized to take account of movement of CERAWeek from Q1, 2016 to Q2, 2017 and movement of our annual maritime event from Q2, 2016 to Q1, 2017. Now for the Q1 results. Revenue was $844 million, an increase of 54% on a reported basis. Adjusted EBITDA was $320 million, an increase of 78%, with margin of 37.9% and margin expansion of 515 basis points on a reported basis. Adjusted EPS was $0.45, an increase of 15%. Relative to revenue, we continue to see trends similar to those discussed throughout 2016. Total Q1 reported revenue growth was 54%. Organic revenue growth was 2%. Acquisitions contributed 55%, and FX was minus 2% headwind. Recurring organic growth was 2%, and non-recurring organic was 4%. Looking at segment performance, Transportation normalized growth was 11%, which included 9% organic, 2% acquisitive and minus 1% FX. Organic revenue growth was comprised of 9% recurring growth and 10% non-recurring growth. We continue to see very strong growth in our automotive business and stable but lower growth in the other transportation businesses. We continue to expect all-in and recurring Transportation organic growth in the high-single digits but also expect non-recurring growth to moderate due to difficult year-over-year comparisons in our recall business. Moving on to Resources, revenue declined 2%, including minus 8% organic, 7% acquisitive and minus 1% FX. The organic revenue decline was comprised of minus 8% recurring and minus 13% non-recurring. In Q1, on a constant currency basis, our Resources' annual contract value, or ACV, which represents the annualized value of recurring revenue contracts, declined approximately $12 million, which was in line with our expectations. We expect flat ACV in Q2 and flat ACV growth on a full year basis. This is due in large part to more stable price environment and more favorable capital spending budgets in 2017 than in the past two years. Our non-recurring energy revenue declined $3 million versus prior year, normalized for CERAWeek timing shift. This decline was primarily due to consulting decline of $1 million versus prior year base of $12 million and software and one times decline of $2 million versus prior year base of $8 million. We expect positive non-recurring revenue growth in Q2 due to the strong performance of our CERAWeek event and improved consulting performance. We are now forecasting the annual average price of oil to be in the mid to high 50s in 2017. CMS declined 5%, which included minus 2% organic and minus 3% FX. Organic revenue was comprised of 1% recurring growth and minus 20% non-recurring. The non-recurring declines were in part due to the continued product rationalization within our TMT business. We expect positive CMS organic revenue growth in Q2 due to lapping of the loss of a significant customer contract in our RootMetrics business in late Q1, 2016. Financial Services' revenue growth was 4%, including organic revenue of 7% and negative 3% FX. Organic revenue growth was comprised of 6% recurring and 30% non-recurring. Information organic growth was 4%, in line with the previous quarter. We saw steady growth across products, with particular strength in both our index and bond pricing businesses. Our processing business delivered 12% organic revenue growth. This was driven by increased market activity in the loans market and mixed activity in the derivatives market, with the volume in rates steady and volume in credit markets lighter. Solutions' organic growth was 10%, a significant improvement on the previous quarter. As indicated during our Q4 earnings call, this was driven by improved levels of non-recurring software license revenue. Our managed service business had another solid quarter and delivered double-digit organic revenue growth. Turning now to profits and margins, Q1 adjusted EBITDA totaled $320 million, up 78% versus a year ago. Our adjusted EBITDA margin was 37.9% and represented margin expansion of 515 basis points. Taking account of Markit prior year Q1 margin, normalized margin expansion for the combined IHS Markit was approximately 200 basis points. Margin expansion benefited from our shared service cost synergies, which were allocated across all segments. In addition, our Transportation and Financial segments benefited from margin flow-through from strong revenue growth. Regarding segment profitability. Transportation's adjusted EBITDA was $90 million with a margin of 39.9%, up 317 basis points. Resources adjusted EBITDA was $80 million with a margin of 40.6%, up 17 basis points. Year-over-year Resources' EBITDA declined $7 million due to the CERAWeek timing shift. CMS' adjusted EBITDA was $29 million with a margin of 22.6%, up 190 basis points. And Financial Services' adjusted EBITDA was $129 million with a margin of 43.7%, up approximately 200 basis points. In the quarter, we recorded $32 million of acquisition-related expense, including severance, retention and contract termination costs related to merger integration activities. Stock-based compensation expense was $75 million and included additional expense from revaluation of market outstanding grants and acceleration of certain share awards associated with severance activities post-merger as well as conversion of IHS PSUs to RSUs. We are expecting full year stock-based compensation expense toward the high end of our $200 million to $220 million guidance range. Our GAAP tax rate was minus 6%, and our adjusted tax rate was 24%. Our effective GAAP tax rate benefited from excess tax benefit of $14 [ph] million associated with vesting our exercise of equity awards and share price increase from date of grant. This benefit is due to the accounting change, which reflects the excess tax benefit from share price increases as income tax benefit. Our GAAP ETR also benefited from merger-related expenses. Neither of these items impacted our adjusted tax rate, which excludes tax benefits from merger-related expenses and equity awards. Our adjusted EPS was $0.45, an increase of $0.06, up 15% versus the prior year. Q1 free cash flow was $179 million. Our trailing 12 month free cash flow was $542 million and represented a conversion rate of 48%. Trailing 12 month free cash flow includes approximately $170 million of restructuring and acquisition-related cash costs. Excluding these cash costs, conversion would have been approximately 63%, in line with our long-term objective of the mid-60s. Turning to the balance sheet, our quarter-end debt balance was $3.7 billion, which represented a gross leverage ratio of approximately 2.6 times on a bank covenant basis. And our quarter-end cash balance was $155 million. In the quarter, we increased our bank credit facility with the addition of a $500 million, one year term loan, and we completed a $500 million, eight year note offering at a 4.75% coupon rate. These proceeds were used to pay down our revolver, and at quarter close, our undrawn revolver balance was approximately $1.2 billion, which provides sufficient liquidity to execute our share repurchase commitments. Our weighted average diluted share count for the quarter was 422 million shares. In the quarter, share repurchases were $592 million or 15.8 million shares, an average price of $37.50. The share repurchases included $492 million of our $1.2 billion buyback commitment as well as approximately $100 million from stock option proceeds. We also executed a $200 million ASR on March 1. We will continue to use a combination of ASRs and open market share repurchases to execute against our repurchase target. We are reaffirming our 2017 guidance, which we provided on our November 14 guidance call. In terms of highlights, this guidance provides for revenue in the range of $3.49 billion to $3.56 billion. This represents 2% to 4% organic revenue growth, negative FX impact of approximately $50 million and acquisitive revenue of slightly less than $20 million from the CARPROOF and OPIS acquisitions. Adjusted EBITDA of $1.375 billion to $1.4 billion, which represents margin of 39.4% at the midpoint. And adjusted EPS of $2.02 to $2.08. As a reminder, to help you with modeling, CERAWeek has moved from Q1 in 2016 to Q2 in 2017, and the Boiler Pressure Vessel Code will be in our second half results this year. Prior year CERAWeek revenue was approximately $15 million at relatively high incremental contribution margin. Boiler Code revenue is approximately $10 million and is relatively low margin. As discussed at the time of the merger announcement, IHS Markit is well positioned to drive attractive shareholder returns given our financial scale, substantial cash generation, return on capital strategy and revenue, expense and tax synergy opportunities. This combination creates a very attractive financial lens. And with that, I will turn the call back over to Jerre.